WO1997017020A1

WO1997017020A1 - Apparatus and method for detecting extrasensory perception

Info

Publication number: WO1997017020A1
Application number: PCT/US1996/017766
Authority: WO
Inventors: John M. Ackerman
Original assignee: Ackerman John M
Priority date: 1995-11-08
Filing date: 1996-10-31
Publication date: 1997-05-15
Also published as: AU1050197A

Abstract

An apparatus and method for detecting a mammal's perception and response to an extracorporeal object positioned near the mammal's body is disclosed. The apparatus measures the change in tonicity of smooth muscles and comprises a substance or object (12), positioner (11), position sensor (14), and computer (19).

Description

APPARATUS AND METHOD FOR DETECTING

EXTRASENSORY PERCEPTION

BACKGROUND OF THE INVENTION 1. Field ofthe Invention

This invention relates to an apparatus and method for detecting a person's perception of an extracorporeal stealth object positioned near the person's body 2. Prior Art The following discussion concerns the detection of measurement of an

animal's physiological response resulting from the presence of an extracorporeal, sensibly invisible object, or "stealth object" positioned close to, but not physically touching the animal. Although the following discussion is largely directed to human beings for exemplary purposes, the discussion may extend or otherwise apply to other life forms, particularly mammals other than man.

In 1926, Born hypothesized that sub-atomic particles can exist in both a particle form and wave form. See LEADERMAN, Leon, The God Particle. Delta Press, 1993, p.171. The wave-particle duality of matter has been confirmed and it is well settled that the location and behavior of matter can best be described only

approximately in terms of quantum mechanical probabilities.

In 1932, Guy Beckley Stearns, MD described the use of pupillary changes to predict the therapeutic potential of homeopathic remedies for patients. See STEARNS, Guy Beckley, The Homeopathic Recorder. Vol.XLVII, No.1 1,

pp.782-793. According to Stearns, when a suitable therapeutic agent is rapidly brought close to a patient without physically touching the patient, a characteristic change in the patient's pupil may be visually observed.

In the mid-1950's Paul Nogier, MD, working at the medical school in

Lyon, France, discovered a manual radial pulse technique useful for detecting a

signal which he referred to as the Vascular Autonomic Signal (VAS). See NOGLER, Paul F.M., Auriculo-Therapy to Auriculo Medicine. Maisonneuve, 1983. In operation, a portion of the wrist overlying the radial artery was palpated

while an acupuncture needle was held close to, but not touching, a patient's ear.

The signal (VAS) at the radial artery could be used for: (a) identifying which acupuncture point(s) on the ear of the patient would be most effective for the treatment of a disease; and (b) which type of acupuncture needle (i.e. stainless

steel, gold, silver, etc.) should most preferably be used to stimulate the identified acupuncture points The Vascular Autonomic Signal (VAS) was recorded in the late 1970's by Navach using infrared reflection and three types of ultrasound, continuous wave

form, Doppler and set angle reflection. See NAVACH, J.H., "The Vascular

Autonomic System Pulse, Recording Techniques", First International Congress of Acupuncture and Auricular Medicine, Mallorca, Spain, September 19, 1980. Navach reported a correlation between changes in a pulse wave at the radial artery

and the relative effectiveness of specific medications for treating illnesses. A computer means was employed to delineate various changes in the VAS when specific medications were held in close proximity to, but not touching, a patient's head. In 1982, Kenyon reported using the manual VAS to test a patient's

tolerance to various foods. KENYON, J N. and LEWITH, G.T., "The Auriculo-

Cardiac Reflex as a Diagnostic Method for Food and Chemical Allergy Testing",

American Journal of Acupuncture, Vol. 10, July-September, 1982, pp.239-243. Navach, using the manual VAS, reported a timed therapeutic window at the radial artery that could be utilized to determine which one of a plurality of

medications was best suited to effect a therapy for a particular disease condition in a patient when each of the plurality of medications was individually and sequentially held close to, but not physically touching, a patient's head. Between 1990 and 1995, the present inventor, working with Kantor,

Sterman and Lee, attempted, with some success using QEEG instrumentation, to

measure an EEG signal in patients while simultaneously and stealthily holding foods for which the patients had known cerebral intolerances close to, but not physically touching, the patient's head. See ACKERMAN, J.M., "A Study of the Vascular Autonomic Response Using the Electroencephalogram", Proceeding of

the Symposium International of Auriculo-Therapy and Auriculo-Medicine. Haug International, Bruxelles, 1994, pg.24. In 1995 Valerie Hunt, Ph.D., reported the detection of a high frequency signal simultaneous with the entry of an object into a subject's autogenous

electromagnetic field. See HUNT, Valerie V., Infinite Mind. Malibu Publishing Co., 1995. The high frequency signal was recorded by telemetry from electrodes attached to the skin of the human subjects after signals from the EEG, EMG and ECG were filtered out. Although such studies are interesting, until now the prior art has not provided an apparatus or method operable by a relatively unskilled

practioner for objectively detecting and measuring changes in the tone of a muscle which change is related to the proximity of an object to a person.

SUMMARY OF THE INVENTION

It is an object of the invention to provide an apparatus operable for detecting a mammal's perception of an extracorporeal object proximal to the mammal 's skin. It is a further object of the invention to provide a method useful for detecting a mammal's response to a change in the distance separating an extracorporeal object from the mammal's skin. It is yet another objective of the invention to provide an apparatus operable for stealthily moving an object toward and away from a subject mammal and detecting and/or measuring a change in the muscle tone of the mammal in response to the distance separating the object from the mammal.

Further, it is an object of the invention to provide a method useful for measuring a change in the tonus of a muscle within the mammal in response to a change in the distance between the mammal and the object when the object

stealthily positioned near the mammal's skin and moved toward and away from the skin.

It is still another object ofthe invention to provide a means for selecting a most effective therapeutic modality for treating a disease from among a plurality of

therapeutic modalities, including determining which vitamins, minerals and dietary supplements a mammal is deficient in, determining the suitability of a particular medication for treating a patient's condition and the ideal dose thereof, identifying allergens, and determining the ideal placement for acupuncture needles.

A person's physiological response to the proximity of an extracorporeal

stealth object may be useful as an adjunctive means for diagnosing and treating certain medical conditions. The features of the invention believed to be novel are set forth with particularity in the appended claims. However, the invention itself, both as to organization and method of operation, together with further objects and advantages thereof may best be understood by reference to the following description taken in conjunction with the accompanying drawings in which:

BRD F DESCRIPTION OF THE DRAWINGS Figure 1 is a schematic view of the apparatus of the present invention

configured for evaluating a change in a person's eye movement or pupillary diameter in response to a change in the position of a nearby stealth object. Figure 2 is a theoretical graphical representation of a mammal's muscle tone when two substances having opposite effects approach the mammal. Figure 3 is a graphical presentation showing a subject's pupillary diameter

observed before, during and subsequent to the approach and retreat of a challenging substance. DESCRIPTION OF THE PREFERRED EMBODIMENTS For the purpose of this disclosure, a "stealth object" shall mean an extracorporeal object which is presented to a mammal in such a manner that the

object has no property which can be sensibly perceived by the mammal, and

includes vitamins, minerals, foods, organic matter, pharmaceutical compounds, medical instrument, or potential allergen, just to name a few. By "sensibly perceived", it is meant that no property possessed by the stealth object can be sensed by a mammal by means of seeing, hearing, smelling, tasting or touching the object due to the

nature ofthe object and/or manner in which the object is presented to the mammal There is a hypothesis that "like" sub-atomic particles are sufficiently individualistic regarding their "charge" that the total aggregate of such particles in any substance, or object containing such a substance, results in a "vector" charge reflected in the form of an inherent electromagnetic signature characteristic of the substance or object containing the substance. The hypothetical electromagnetic signature, being an intrinsic property of a substance (or object containing such a substance) and characteristic thereof, is

hypothesized by Navach to induce oscillations in specific chemical compounds within tissue comprising acupuncture points in a patient's body when the substance is positioned proximal to the patient's body. These oscillating corporeal chemical compounds then transmit information related to the vibratory state by serial

induction along meridians within the body to the thalamus where the information is

transferred to the autonomic nervous system. The vibratory information then

induces involuntary radial artery smooth muscle modified pulse wave changes Such changes, the presence and magnitude of which are responsive to the vibratory information, provide a physiological signal which may be correlated, in time, with a stimulus held close to, but not physically touching, the human body.

Without wishing the scope of the present invention to be restricted to a particular hypothesis, the present inventor further hypothesizes that an apparatus which records physiological signals related to changes in smooth muscle tone can be adapted to simultaneously document the correlation, in time, between smooth

muscle tonal change and objects placed near, but not physically touching, a mammal. Such objects, "stealth objects", are postulated to emit, or possess as a property thereof, characteristic electromagnetic signatures. In addition, another hypothesis would have that the mere entry of an object

or substance into a mammal's electromagnetic field, irrespective of the presence or

absence of any inherent "vector" electromagnetic signature, may induce oscillations of chemical compounds within the tissues of a mammal as previously described. Production of the aforementioned signal may be objectively detected,

measured and analyzed in a fashion similar to the use of the subjective timed therapeutic window of the manual VAS. This data may then be used to provide adjunctive data to assist clinicians to determine the usefulness of specific medications and/or remedies for specific disorders. One type of existing and accepted objective technology used for detecting

involuntary muscular activity is infrared video technology (IVT). IVT is widely accepted, having been used in the courtroom as well as in the field of ophthalmology. IVT employs infrared light to make "dark" measurements of pupillary size because the iris reflex is insensitive to fluctuations of intensity in the

longer wavelength infrared light IVT can also be used to measure horizontal and

vertical movement of the eye The present inventor believes IVT may have

additional utility as an adjunctive means for determining appropriate medication and/or remedies for treating a mammal's disease simply by positioning samples of such medications and/or remedies close to, but not physically touching, the mammal's head, or other part ofthe mammal's body

One type of device for monitoring muscle tone is an infrared video device offered by Eye Dynamics, of 2301 W 205^th Street, Unit 106, Torrance, California, USA, which could be adapted for detecting and recording temporal changes in a

person's pupillary diameter in accordance with the experimental design shown in Figure 1 The Eye Dynamic InfraRed/Video goggles, with their accompanying computer hardware and software are designed to track the eye in total darkness The are discussed in U.S Patent No 4,815,839 to Waldorf The InfraRed/Video goggles measure pupil size changes, (which results from movement of the circular smooth muscle) and can be used to track movement of the subject eyes, and provide a temporal record thereof The InfraRed video technology has previously been used in tracking eye movement in total darkness for use in diagnosing electronystagmographic movement, (jerking movement of eye), and for diagnosis

of multiple sclerosis Another application is for detecting the impairment of a psychoactive effect of a substance on the brain

While the vertical and horizontal movements of the eye within the globes comprising the goggles is controlled by eye skeletal muscles enervated by cranial nerves Lu, IV and VI, which nerves are normally considered voluntary muscles

groups, involuntary horizontal and vertical movement of the eyes has been

observed which is associated with changing the separation between a stealth object in relation to a person's body. The present inventor has extremely sensitive fingers. When the inventor

palpates the radial pulse of a patient, changes in the smooth muscle tone ofthe wall can be detected when a stealth object is brought close to the patient's body This is very different from taking the pulse. While the physician is feeling the smooth muscle tone of the wall of the radial artery, the stealth object will be brought close

to the body, e.g. head, of the patient. Concurrently, a change in the tone of the smooth muscle ofthe radial artery can be felt. One can then quantitatively measure the duration of such changes, and determine how long these smooth muscle changes persist for various stealth objects. The contraction or relaxation of the

smooth muscles can be recorded in response to the proximity ofthe stealth object. Turning now to Figure 1, an apparatus 10 in accordance with the present invention is shown. A stealth object comprising a substance 12, e.g. a possible medication, is placed at a distance d from the patient's head 13. A positioner 11 moves the stealth object 12 reciprocally in the direction of the double-headed arrow in response to a computer signal l la thereby changing d. A position sensor

14 records the value of d and inputs the value of d to a computer 19. A source of infrared light 15 illuminates the eyes 16a and 16b ofthe subject 13 through goggles 17. The goggles 17 are transparent to infrared light but block transmission of visible light Movement sensors 18a and 18b gather light reflected from portions of the eyes 16a and 16b and are adapted to detect movement of the eye or a portion thereof and generate a signal quantitatively related to the motion The movement sensors respective signal inputs are input to computer 19 along with the

value of d The computer 19 analyzes the signals received from motion sensors 18a and 18b for incremental values of d and outputs the signals to a recorder 20 If the smooth muscle contracts, this suggests that the patient rejects the medication for one of two reasons either because (a) it is toxic and/or an allergen, or (b) there is a sufficient amount of that substance already present in the subject's body A theoretical representation illustrative of this hypothesis is shown graphically in Figure 2 The distance d between the test substance 12 and the patient's body 13 is important For example, if the distance is substantially over six centimeters, the sensitivity might be reduced If, however, the substance is brought too close to the

body, a change in polarity might occur If the smooth muscle relaxes, this means

the body is comfortable with the substance and can achieve homeostasis by the administration thereof. If the relaxation persists for between 9 and 18 seconds, this indicates that the substance may have therapeutic potential for the subject being

tested If the relaxation time is between 10-12 seconds, the substance has optimal

therapeutic potential. One can also measure how much of the substance is needed in a period, such as a day, by adding an additional amount of the substance, until the smooth muscle changes from relaxation to contraction, which indicates the

upper end of the dose. One can then titer back or forth to optimize the dose The inventor has used vitamins, minerals, amino acids, antibiotics, anesthetics, blood pressure medications, cardiac medications, allergy medications, various foods and even jewelry as the stealth object for testing this methodology. This method has been used to select the appropriate composition of needles (from

gold, silver, stainless steel, etc.) for acupuncture treatment, as well as to determine precisely where to insert the needles. As the needle is crossed over a point where it needs to be inserted, if the radial artery wall relaxes, this indicated the correct location has been located. As mentioned in the discussion of prior art, Dr. Nogier

reported using this method with acupuncture needles. As noted above, the inventor has developed the ability to recognize and interpret changes in the muscle tone of the walls of the radial artery. However, most physicians have neither the tactile sensitivity nor the training to do this. As a result, heretofore, neither this important methodology nor an apparatus adapted for

the practice thereof has been available to physicians or other health care practitioners. The apparatus ofthe present invention is similar to equipment which has been adapted for measuring changes in smooth muscles tissue in the circular smooth muscle ofthe eyes by measuring changes in the size ofthe pupil under dark

conditions and/or for measuring and analyzing the horizontal and vertical movement of the eyes in the globe caused by involuntary movement of eye skeletal muscles enervated by cranial nerves LU, IV, and VI. Example

In this experiment, four people were present within a dark room. Person 1 , the subject, was seated in a chair wearing infrared transparent goggles. Person 2, a computer operator, was seated at a computer Person 3, the "presentor" of a stealth object, stood to the right ofthe subject (Person 1) Person 4, the "challenge presentor" had a flashlight and stood near a table a few feet to the right of Person 3 The table

supported a plurality of glass vials containing various known therapeutic and placebo agents Person 4 selected an Agent and presented the Agent to Person 3 Person 3 did not know which agent Person 4 had given him The order in which the agents were presented was known only to Person 4 Person 3 (the presentor) held the Agent 6 cm

from the subject's right ear Person 2 entered the time at which the Agent was presented in the computer The signal outputs from the motion sensors (miniature video cameras) in the goggles was recorded providing a measure of eye movement The Agent was then removed signaling the end of a "therapeutic window" and the process repeated for each Agent. The experiment was conducted in a dark room The result from a trial on one subject for a substance is shown in Figure 3. In the above example, the change in pupillary diameter occurred 2 5 seconds after the substance was withdrawn from the proximal position Thus, the change in muscle tone may occur either during the positioning of a challenging object near a patient or after withdrawing the object. Such a change may also include a reduction in the observed noise level in the muscle tone. Using IVR, the inventor has measured

significant change in pupil size and also involuntary horizontal and vertical eye movement when a stealth object is brought close to a patient's body.

While particular embodiments ofthe present invention have been illustrated

and described, it would be obvious to those skilled in the art that various other

modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention

What I claim is:

Claims

1 A method for detecting a mammal's perception of and response to an extracorporeal object presented proximal to the mammal's body wherein the mammal has at least one eye, the method comprising measuring changes in the tonus of a muscle within said eye, a change related to the mammal's sensitivity to said object

2 The method of claim 1 , wherein the method comprises measuring involuntary horizontal and vertical movements ofthe mammal's eye

3 The method of Claim 1, wherein such muscle comprises a muscle controlling the diameter ofthe pupil within the eye

4 The method of claim 1, wherein the extracorporeal object is selected from a vitamin, mineral, food, plant matter, pharmaceutical compound, medical instrument, or potential allergen

5 The method of claim 1, wherein the method is used to determine the

compatibility ofthe stealth object with the mammal's health, such as to determine the suitabibty of various dietary supplements and medications to a mammal's medical condition and health, to determine allergies, and to determine dosage information 6. An apparatus operable for detecting a change in a person's muscle tone

in response to a change in the distance between the person's skin and a material substance positioned near the person's skin comprising: (a) a substance container adapted to contain and support a

substance, (b) a translation means having a central signal input port, said translation means being operable for continually and reciprocally moving said substance container to change the distance between said substance container and the person in response to a control signal; (c) a programmable computer means adapted to provide a control signal to said control signal input port of said translation means; (d) position sensing means operable for measuring the distance separating said substance container from the person and

presenting a distance input signal related to said distance to said programmable computer means; (e) tonicity measuring means adapted for releasable attachment to the person's body and operable for measuring the tonicity of a

muscle within the person and presenting a signal related to said measurement of tonicity to said programmable computer means; (f) recording means adapted to receive an output signal from said

computer means and form a display thereof, wherein said 1 output signal from said programmable computer means is a

2 measure of said tonicity of said muscle corresponding to the

3 distance between said substance container and the person, and

4 wherein a change in said measurement of muscle tonicity

5 associated with a change in said distance is indicative of the

6 person's sensitivity to a substance contained within the

7 substance container.

8